Results 31 to 40 of about 4,283,849 (254)

Autonomic cardiovascular reflex control of hemodynamics during exercise in heart failure with reduced ejection fraction and the effects of exercise training [PDF]

Reviews in Cardiovascular Medicine, 2022
Heart failure with reduced ejection fraction is associated with increased exercise intolerance, morbidity, and mortality. Importantly, exercise intolerance in heart failure with reduced ejection fraction is a key factor limiting patient quality of ...
Natasha G. Boyes, Darcy D. Marciniuk, Haissam Haddad, Corey R. Tomczak   +3 more
doaj   +1 more source

Obesity paradox in chronic heart failure with moderately reduced or preserved left ventricular ejection fraction: impact on a prognosis for patients according to a five-year follow-up

Zaporožskij Medicinskij Žurnal, 2023
Aim. To investigate the obesity paradox by studying the impact of overweight and abdominal obesity on the prognosis in chronic heart failure (CHF) patients with moderately reduced or preserved left ventricular ejection fraction (LVEF) by five-year follow-
P. P. Bidzilya, V. H. Kadzharian, M. V. Bychko   +2 more
doaj   +1 more source

SGLT2 inhibitors in heart failure with reduced ejection fraction

The Egyptian Heart Journal, 2021
Sodium – glucose co-transporter 2 (SGLT2) inhibitors reduce blood glucose by inhibiting reabsorption of glucose from the proximal renal tubules. Initial studies showed that apart from reducing blood glucose they also reduce the combined endpoint of ...
Uday Sankar Das, Aritra Paul, Suvro Banerjee   +2 more
doaj   +1 more source

Right ventricular volumes and function in thalassemia major patients in the absence of myocardial iron overload [PDF]

, 2010
Aim: We aimed to define reference ranges for right ventricular (RV) volumes, ejection fraction (EF) in thalassemia major patients (TM) without myocardial iron overload.Methods and results: RV volumes, EF and mass were measured in 80 TM patients who had ...
Maciej Garbowski, He, TG, Maceira, A, Francisco Alpendurada, Banya Winston, He, T, Taigang He, Carpenter, JP, Smith, GC, Kirk, P, Shah, F, Maceira Alicia, Porter, JB, John B Porter, Banya, W, He Taigang, Walker, JM, Kirk Paul, Alicia Maceira, Alpendurada Francisco, Gillian C Smith, Porter John B, Smith Gillian C, Farrukh Shah, Pennell, DJ, Shah Farrukh, Pennell Dudley J, Deac Monica, Dudley J Pennell, Alpendurada, F, Paul Kirk, Winston Banya, Carpenter John-Paul, John-Paul Carpenter, Deac, M, J Malcolm Walker, Garbowski, M, Walker J Malcolm, Garbowski Maciej, Monica Deac   +39 more
core   +1 more source

Dapagliflozin use in routine management of heart failure with reduced ejection fraction: outcomes from the Bulgarian cohort of a large observational study (EVOLUTION-HF) [PDF]

Българска кардиология
Introduction: The EVOLUTION-HF is a prospective, multinational, real-world study designed to describe the demographic and clinical characteristics of patients initiating dapaglifl ozin for heart failure with reduced ejection fraction (HFrEF) in
I. Gruev, K. Bletzova, I. Deenichina, G. Goranov, K. Gospodinov, G. Gyuzelev, M. Mihalev, S. Petranov, S. Yovev, V. Velchev   +9 more
doaj   +3 more sources

Clinical characteristics and outcomes of heart failure with preserved, mildly reduced, and reduced ejection fraction: A 6-month follow-up study

Medical Journal of Babylon, 2022
Background and Objective: Heart failure is a major public health problem with 64.3 million people affected all over the world, and it is an important cause for hospital admission and mortality.
Goran Adnan Rahman, Abdulkareem Abdulwahab Al-Othman   +1 more
doaj   +1 more source

Pharmacological management of heart failure with reduced ejection fraction

, 2022
Heart failure with reduced ejection fraction is a disease with a high prevalence, cost, and mortality rate. However, in recent years, new diagnostic and management breakthroughs have been made, as well as new pharmacological and non-pharmacological ...
Oladunjoye, Kayode
core  

Correlation of β-adrenergic reactivity of erythrocyte membranes with clinical characteristics of patients with coronary artery disease and HF with preserved and reduced ejection fraction

Российский кардиологический журнал
Aim. To evaluate β-adrenergic reactivity of erythrocyte membranes (β-ARM) depending on clinical parameters in patients with heart failure (HF) with preserved and reduced ejection fraction (EF), who had prior myocardial infarction.Material and methods ...
E. F. Muslimova, V. A. Korepanov, T. Yu. Rebrova, S. L. Andreev, S. A. Afanasiev   +4 more
doaj   +1 more source

Sodium-Glucose Co-transporter-2 Inhibitors in Heart Failure with Preserved Ejection Fraction: A Breakthrough in Improvement of Clinical Outcomes?

, 2022
The conventional conception of the therapy of heart failure (HF) with reduced ejection fraction has been recently modified by adding sodium-glucose co-transporter-2 (SGLT2) inhibitors to the combination consisting of beta blockers, mineralocorticoid ...
Alexander A. Berezin, Alexander E. Berezin   +1 more
core   +1 more source

Coronary Artery Disease and Prognosis of Heart Failure with Reduced Ejection Fraction [PDF]

, 2023
Our aim was to determine the prognostic impact of coronary artery disease (CAD) on heart failure with reduced ejection fraction (HFrEF) mortality and readmissions.
Albert Ariza-Sole, Vazquez-Garcia, Rafael, Martínez-Sellés, Manuel, Lourdes Vicent, José R. González-Juanatey, Álvarez García, Jesús, Vicent, Lourdes, Ariza-Sole, Albert, Rafael Vazquez-Garcia, González-Juanatey, José R, Ramón Bover, Ariza Sole, Albert, Domingo Pascual-Figal, Pascual-Figal, Domingo, Fernando Worner, Manuel Martínez-Sellés, Francisco Fernández-Avilés, Martínez-Sellés D Oliveira Soares, Manuel, Javier Segovia, Álvarez-García, Jesús, Rivera, Miguel, Worner, Fernando, González Juanatey, José R., Miguel Rivera, Vazquez Garcia, Rafael, Fernández Avilés, Francisco, Pascual Figal, Domingo, Gonzalez-Juanatey, Jose R., Fernández-Avilés, Francisco, Segovia, Javier, Pascual-Figal, Domingo A, Bover, Ramón, Jesús Álvarez-García   +32 more
core   +1 more source